Journal of Cancer Research and Clinical Oncology

, Volume 119, Issue 12, pp 700–701

Why does a higher repseonse rate to chemotherapy correlate poorly with improved survival?

Authors

  • Maurie Markman
    • Cleveland Clinic Cancer CenterThe Cleveland Clinic Foundation
    • the Department of Hematology/Medical OncologyThe Cleveland Clinic Foundation
Editorial

DOI: 10.1007/BF01195339

Cite this article as:
Markman, M. J Cancer Res Clin Oncol (1993) 119: 700. doi:10.1007/BF01195339

Copyright information

© Springer-Verlag 1993